New Key Statistics Module, Z-Score and F-Score
NAS:OCUL Key Ratios
Market Cap $ M | 876.67 |
Enterprise Value $ M | 468.19 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.15 |
Price/Sales | 8.73 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 59.00 |
EPS (TTM) $ | -1.35 |
Beneish M-Score | -2.48 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -4.61 |
EV-to-EBITDA | -4.77 |
PEG | -- |
Shares Outstanding M | 154.89 |
Net Margin (%) | -192.62 |
Operating Margin % | -152.82 |
Pre-tax Margin (%) | -192.62 |
Quick Ratio | 21.29 |
Current Ratio | 21.39 |
ROA % (ttm) | -47.85 |
ROE % (ttm) | -110.88 |
ROIC % (ttm) | -347.57 |
Dividend Yield % | -- |
Altman Z-Score | 2.63 |
OCUL Number of Guru Trades
OCUL Volume of Guru Trades
Gurus Latest Trades with NAS:OCUL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:OCUL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ocular Therapeutix Inc Insider Transactions
No Available Data
News about NAS:OCUL
Total 0- 1